{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:33:10Z","timestamp":1758637990316},"reference-count":28,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1136\/bjophthalmol-2014-306465","type":"journal-article","created":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T02:37:22Z","timestamp":1426300642000},"page":"1004-1008","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of intravitreal ranibizumab injections on aqueous humour concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisation"],"prefix":"10.1136","volume":"99","author":[{"given":"Ciro","family":"Costagliola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Semeraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"dell'Omo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario R","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Aceto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo","family":"Mastropasqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Porcellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,3,13]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2014-306465-1","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/bjo.2005.074716","article-title":"Choroidal neovascularisation in pathological myopia: an update in management","volume":"89","author":"Chan","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306465-2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10792-013-9844-1","article-title":"Myopia onset and progression: can it be prevented?","volume":"34","author":"Russo","year":"2014","journal-title":"Int Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306465-3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ophtha.2014.07.030","article-title":"Visual consequences of refractive errors in the general population","volume":"122","author":"Verhoeven","year":"2015","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2014-306465-4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.preteyeres.2012.04.001","article-title":"Choroidal neovascularization in pathological myopia","volume":"31","author":"Neelam","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"key-10.1136\/bjophthalmol-2014-306465-5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00417-009-1285-1","article-title":"Bevacizumab for choroidal neovascularization secondary to pathologic myopia: Is there a decline of the treatment efficacy after 2 years?","volume":"248","author":"Voykov","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306465-6","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.ophtha.2013.06.010","article-title":"Ranibizumab in myopic choroidal neovascularization: the 12-month results from the REPAIR study","volume":"120","author":"Tufail","year":"2013","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2014-306465-7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ophtha.2013.10.023","article-title":"RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia","volume":"121","author":"Wolf","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2014-306465-8","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bjophthalmol-2012-302973","article-title":"Intravitreal anti-VEGF therapy for choroidal neovascularisation secondary to pathological myopia: 4-year outcome","volume":"97","author":"Ruiz-Moreno","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306465-9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1755-3768.2009.01717.x","article-title":"Vascular endothelial growth factor in the aqueous humour in eyes with myopic choroidal neovascularization","volume":"89","author":"Sawada","year":"2011","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"key-10.1136\/bjophthalmol-2014-306465-10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajo.2011.06.001","article-title":"Aqueous humor levels of vascular endothelial growth factor before and after intravitreal bevacizumab in type 3 versus type 1 and 2 neovascularization. A prospective, case-control study","volume":"153","author":"Dell\u2019 Omo","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306465-11","first-page":"7","article-title":"Structural and comparative analysis of the mouse gene for pigment epithelium-derived factor (PEDF)","volume":"4","author":"Singh","year":"1998","journal-title":"Mol Vis"},{"key":"key-10.1136\/bjophthalmol-2014-306465-12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10384-008-0645-4","article-title":"Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab","volume":"53","author":"Matsuyama","year":"2009","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306465-13","first-page":"2265","article-title":"Aqueous humor concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in high myopic patients","volume":"18","author":"Shin","year":"2012","journal-title":"Mol Vis"},{"key":"key-10.1136\/bjophthalmol-2014-306465-14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00417-011-1889-0","article-title":"Recent trends in the management of maculopathy secondary to pathological myopia","volume":"250","author":"Mitry","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306465-15","article-title":"Correlation of macular choroidal thickness with concentrations of aqueous vascular endothelial growth factor in high Myopia","author":"Chen","journal-title":"Curr Eye Res"},{"key":"key-10.1136\/bjophthalmol-2014-306465-16","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/IAE.0b013e31818358b2","article-title":"Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia","volume":"28","author":"Chan","year":"2008","journal-title":"Retina Phila Pa"},{"key":"key-10.1136\/bjophthalmol-2014-306465-17","article-title":"Short-term effect of intravitreal ranibizumab on intraocular concentrations of VEGF-A and PEDF in neovascular glaucoma","author":"Wang","journal-title":"Clin Experiment Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306465-18","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1167\/iovs.09-4892","article-title":"Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type-specific knockout mouse models of choroideremia","volume":"51","author":"Tolmachova","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2014-306465-19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ajo.2005.05.037","article-title":"Low levels of pigment epithelium-derived factor in highly myopic eyes with chorioretinal atrophy","volume":"140","author":"Ogata","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306465-20","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3760\/cma.j.issn.0366-6999.20130188","article-title":"Anti-vascular endothelial growth factor: the future treatment of choroidal neovascularization in pathologic myopia?","volume":"126","author":"Zhu","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"key-10.1136\/bjophthalmol-2014-306465-21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajo.2011.01.053","article-title":"Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration","volume":"152","author":"Day","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306465-22","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1167\/iovs.08-2201","article-title":"Regulation of pigment epithelium-derived factor production and release by retinal glial (M\u00fcller) cells under hypoxia","volume":"49","author":"Lange","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2014-306465-23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.clinbiochem.2005.11.013","article-title":"Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions","volume":"39","author":"Tong","year":"2006","journal-title":"Clin Biochem"},{"key":"key-10.1136\/bjophthalmol-2014-306465-24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00417-003-0838-y","article-title":"Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium","volume":"242","author":"Martin","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306465-25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ajo.2005.10.012","article-title":"Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization","volume":"141","author":"Tong","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306465-26","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0006-291X(03)00446-7","article-title":"Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells","volume":"303","author":"Ohno-Matsui","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"key-10.1136\/bjophthalmol-2014-306465-27","doi-asserted-by":"crossref","first-page":"476525","DOI":"10.1155\/2013\/476525","article-title":"Topical nonsteroidal anti-inflammatory drugs for macular edema","volume":"2013","author":"Russo","year":"2013","journal-title":"Mediators Inflamm"},{"key":"key-10.1136\/bjophthalmol-2014-306465-28","doi-asserted-by":"crossref","first-page":"e41511","DOI":"10.1371\/journal.pone.0041511","article-title":"Long-term retinal PEDF overexpression prevents neovascularization in a murine adult model of retinopathy","volume":"7","author":"Haurigot","year":"2012","journal-title":"PLoS ONE"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2014-306465","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T21:08:59Z","timestamp":1717794539000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2014-306465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,13]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,6,22]]},"published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1136\/bjophthalmol-2014-306465"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2014-306465","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,13]]}}}